Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2014);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;9.351;Q1;193;27;71;3483;1464;70;21.25;129,00;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;20425;Nature Reviews Drug Discovery;journal;14741776;9.338;Q1;289;243;689;8808;6808;306;22.27;36,25;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
3;21191;Pharmacological Reviews;journal;15210081, 00316997;9.152;Q1;210;28;107;12841;2405;105;19.61;458,61;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
4;4700152457;Nano Today;journal;17480132;7.152;Q1;119;68;194;5667;2419;121;15.13;83,34;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;5.062;Q1;201;84;270;6223;2693;237;12.36;74,08;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.877;Q1;278;137;464;20537;7738;413;17.41;149,91;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;01637258;4.048;Q1;180;108;317;21251;3302;313;11.12;196,77;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X;3.821;Q1;204;334;870;16744;6094;761;7.66;50,13;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;12611;Drug Resistance Updates;journal;13687646, 15322084;3.5780000000000003;Q1;100;10;63;1013;694;59;11.15;101,30;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.454;Q1;194;313;918;34008;5924;895;6.28;108,65;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;26371;Natural Product Reports;journal;02650568, 14604752;3.42;Q1;157;95;223;12958;2317;213;10.08;136,40;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
12;19700176055;F1000 Biology Reports;journal;17404118;3.327;Q1;27;0;52;0;280;52;4.69;0,00;United Kingdom;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
13;18148;Pain;journal;03043959;3.326;Q1;238;385;1234;16392;6766;929;6.34;42,58;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
14;12455;Molecular Therapy;journal;15250024, 15250016;3.213;Q1;158;245;822;9286;5056;669;7.24;37,90;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.01;Q1;166;190;583;9320;3174;556;5.81;49,05;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;2.812;Q1;58;8;15;1415;99;15;6.6;176,88;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
17;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.64;Q1;173;220;797;6156;4868;709;7.08;27,98;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
18;21000196010;Topics in antiviral medicine;journal;21615853;2.639;Q1;37;18;58;279;317;56;5.53;15,50;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
19;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.5340000000000003;Q1;119;39;99;6938;833;96;9.11;177,90;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.52;Q1;127;125;406;7107;1998;377;5.44;56,86;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.513;Q1;110;801;1594;38420;8743;1568;5.31;47,97;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
22;23010;Journal of Controlled Release;journal;01683659;2.438;Q1;237;503;1484;32761;11234;1402;8.86;65,13;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
23;5100155080;Neurotherapeutics;journal;19337213;2.4330000000000003;Q1;100;79;208;7345;1174;194;5.92;92,97;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
24;4400151524;Particle and Fibre Toxicology;journal;17438977;2.411;Q1;83;73;148;4148;1285;138;7.97;56,82;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
25;20435;Neuropharmacology;journal;00283908;2.41;Q1;150;426;1178;33039;6353;1148;5.76;77,56;United Kingdom;Elsevier Ltd.;1962-ongoing;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
26;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.361;Q1;232;1101;2922;38413;14900;2714;5.38;34,89;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
27;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.298;Q1;172;708;1615;20784;8462;1321;6.21;29,36;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
28;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.298;Q1;186;165;658;8459;3025;632;4.6;51,27;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
29;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.24;Q1;240;793;2467;41982;14611;2401;5.86;52,94;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
30;19427;Advances in Pharmacology;book series;10543589;2.233;Q1;68;46;104;6266;516;58;10.33;136,22;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;15576;European Neuropsychopharmacology;journal;0924977X;2.209;Q1;100;193;405;10748;2150;383;4.64;55,69;Netherlands;Elsevier BV;1990-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
32;20084;British Journal of Pharmacology;journal;00071188;2.202;Q1;190;429;1482;32328;7632;1421;5.25;75,36;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
33;24749;Addiction Biology;journal;13556215, 13691600;2.194;Q1;70;101;260;4998;1353;257;5.45;49,49;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
34;20681;Current Opinion in Pharmacology;journal;14714892;2.084;Q1;120;115;368;6573;1832;345;5.33;57,16;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
35;20063;Biochemical Pharmacology;journal;00062952;2.079;Q1;181;338;1069;22759;5696;923;6.35;67,33;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
36;21100225611;Advanced healthcare materials;journal;21922640, 21922659;2.068;Q1;63;229;276;12736;1621;271;5.98;55,62;United Kingdom;John Wiley and Sons Ltd;2012-ongoing;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
37;21169;Pharmacological Research;journal;10436618, 10961186;2.031;Q1;118;112;432;8106;2308;417;5.69;72,38;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
38;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.99;Q1;78;118;384;11384;1810;367;5.02;96,47;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
39;23916;Environmental Pollution;journal;02697491, 18736424;1.987;Q1;194;464;1424;21838;7121;1386;4.68;47,06;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
40;26380;Drug and Alcohol Dependence;journal;03768716;1.977;Q1;151;410;1049;18989;4366;1026;4.01;46,31;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
41;21782;Psychopharmacology;journal;00333158;1.955;Q1;181;443;1244;26363;5229;1170;4.19;59,51;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
42;21100207003;Theranostics;journal;18387640;1.955;Q1;69;98;201;6449;1618;181;8.94;65,81;Canada;Ivyspring International Publisher;2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
43;20624;Clinical Pharmacokinetics;journal;03125963;1.928;Q1;150;90;201;5753;1195;190;5.87;63,92;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
44;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.924;Q1;93;238;457;12873;2125;438;4.41;54,09;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
45;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.876;Q1;106;187;417;8597;3179;402;7.4;45,97;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
46;21196;Drug Discovery Today;journal;13596446;1.865;Q1;157;249;470;15863;2907;444;6.79;63,71;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
47;25218;Toxicological Sciences;journal;10960929, 10966080;1.813;Q1;164;272;872;11158;4167;824;4.39;41,02;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
48;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.809;Q1;209;264;1042;11802;4634;1007;4.56;44,70;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
49;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.793;Q1;70;15;64;1958;376;57;6.12;130,53;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
50;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.7919999999999998;Q1;143;364;827;15417;3408;776;3.99;42,35;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
51;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.789;Q1;114;191;733;13551;3230;679;4.3;70,95;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
52;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.778;Q1;30;48;95;1100;418;84;5.09;22,92;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
53;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.73;Q1;89;53;207;1909;868;196;4.55;36,02;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
54;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;1.727;Q1;43;81;142;3961;665;128;5.2;48,90;United States;Cell Press;2012-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
55;5400152706;Nanotoxicology;journal;17435390, 17435404;1.714;Q1;72;96;219;5155;1539;214;6.44;53,70;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
56;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.711;Q1;161;250;777;11328;4079;768;4.99;45,31;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
57;28792;Cancer Biology and Therapy;journal;15384047;1.6880000000000002;Q1;101;198;594;7743;2190;531;3.46;39,11;United States;Landes Bioscience;2002-ongoing;"Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2)"
58;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.6669999999999998;Q1;116;115;341;3652;1053;326;3.05;31,76;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
59;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.664;Q1;98;48;127;7062;729;112;5.79;147,13;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
60;24763;Addictive Behaviors;journal;03064603;1.663;Q1;114;307;707;13256;2419;702;3.23;43,18;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
61;23109;Journal of Psychopharmacology;journal;02698811;1.659;Q1;106;137;484;7922;1999;450;4.63;57,82;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
62;19617;Antiviral Research;journal;01663542;1.653;Q1;108;211;600;10898;2482;575;4.55;51,65;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
63;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.648;Q1;78;79;193;3479;947;189;4.83;44,04;United Kingdom;Nature Publishing Group;2001-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
64;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.6469999999999998;Q1;81;118;366;13886;1457;344;3.94;117,68;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
65;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.641;Q1;110;427;1077;20747;5737;1053;5.1;48,59;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
66;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.633;Q1;89;30;89;4924;501;85;5.81;164,13;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
67;19600166320;Protein & Cell;journal;16748018, 1674800X;1.625;Q1;48;120;349;5989;1039;318;3.36;49,91;Germany;Springer Verlag;2010-ongoing;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
68;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.619;Q1;59;151;403;6212;1468;308;4.63;41,14;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
69;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.61;Q1;81;90;246;3503;870;227;3.45;38,92;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
70;110172;Progress in Drug Research;book series;0071786X;1.595;Q1;38;23;15;2373;66;13;0.0;103,17;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
71;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.587;Q1;64;60;276;4417;982;260;4.35;73,62;Germany;Springer Verlag;2006-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
72;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.5830000000000002;Q1;102;145;362;7453;1467;350;4.12;51,40;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
73;22378;Vascular Pharmacology;journal;15371891;1.577;Q1;86;74;182;3941;724;164;4.38;53,26;Netherlands;Elsevier BV;2002-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1); Physiology (Q1)"
74;21100214102;Frontiers in Pharmacology;journal;16639812;1.56;Q1;62;278;447;21227;1892;428;4.34;76,36;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
75;21790;Antiviral Therapy;journal;13596535;1.541;Q1;78;107;486;3662;1541;456;3.29;34,22;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;29311;Current Cancer Drug Targets;journal;15680096;1.533;Q1;85;66;265;6080;1048;246;4.17;92,12;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
77;20783;Expert Review of Vaccines;journal;14760584;1.533;Q1;75;168;467;14550;1770;393;4.56;86,61;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
78;22072;Current Gene Therapy;journal;15665232;1.503;Q1;65;45;141;3701;526;127;3.17;82,24;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
79;24604;Archives of Toxicology;journal;14320738, 03405761;1.495;Q1;96;188;534;12342;2736;453;6.33;65,65;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
80;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.487;Q1;131;275;769;10603;2854;610;4.51;38,56;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
81;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.481;Q1;138;244;728;10830;3503;713;4.37;44,39;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
82;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.477;Q1;82;61;158;3142;482;154;2.95;51,51;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
83;145164;Human Genomics;journal;14739542, 14797364;1.446;Q1;49;21;87;778;282;79;2.38;37,05;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
84;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.445;Q1;144;220;707;11311;2931;676;4.09;51,41;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
85;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.4340000000000002;Q1;153;307;1003;15186;4356;990;4.38;49,47;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
86;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.431;Q1;94;143;452;11529;1764;435;4.31;80,62;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
87;84948;Expert Opinion on Drug Delivery;journal;17425247;1.423;Q1;88;147;360;12018;1876;352;5.22;81,76;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
88;19600166302;Current molecular pharmacology;journal;18744702;1.419;Q1;34;18;77;1656;269;69;3.23;92,00;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
89;18071;Neurotoxicity Research;journal;10298428;1.4;Q1;65;83;250;5215;958;242;4.18;62,83;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
90;20664;Current Drug Targets;journal;13894501;1.395;Q1;92;118;564;12855;1981;508;3.5;108,94;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
91;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.389;Q1;44;88;283;4855;968;266;3.48;55,17;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
92;18075;Neurotoxicology and Teratology;journal;08920362;1.385;Q1;89;72;223;3797;858;209;3.42;52,74;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
93;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.35;Q1;191;286;843;12581;3710;805;4.1;43,99;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
94;22454;International Journal of Pharmaceutics;journal;03785173;1.347;Q1;190;754;2237;28140;10068;2177;4.28;37,32;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
95;13250;Expert Opinion on Biological Therapy;journal;14712598;1.3259999999999998;Q1;75;164;502;11723;1901;478;4.12;71,48;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
96;23053;Journal of Natural Products;journal;01633864, 15206025;1.3259999999999998;Q1;124;390;1106;12471;4399;1068;4.19;31,98;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
97;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.3230000000000002;Q1;89;131;352;5452;1024;309;3.24;41,62;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
98;4000148406;Clinical Toxicology;journal;15563650;1.318;Q1;85;153;475;3982;1452;336;4.18;26,03;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
99;21353;Expert Opinion on Therapeutic Patents;journal;13543776;1.31;Q1;61;102;324;8692;1271;323;4.43;85,22;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
100;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.306;Q1;100;501;1290;20836;6779;1261;5.07;41,59;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1)"
101;18966;Mutagenesis;journal;02678357, 14643804;1.304;Q1;82;57;279;2193;1019;269;3.02;38,47;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
102;144771;Clinical Trials;journal;17407753, 17407745;1.3019999999999998;Q1;55;88;285;2130;488;232;2.2;24,20;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
103;4000148019;AAPS Journal;journal;15507416;1.298;Q1;96;132;292;5140;1308;278;4.3;38,94;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
104;25125;Journal of Analytical Toxicology;journal;01464760;1.298;Q1;69;112;297;2587;907;284;3.34;23,10;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
105;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.295;Q1;55;122;206;3932;527;152;3.27;32,23;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
106;18073;NeuroToxicology;journal;0161813X;1.293;Q1;102;147;437;8195;1658;411;4.02;55,75;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
107;21455;Progress in Medicinal Chemistry;book series;00796468;1.293;Q1;33;5;18;534;61;9;9.0;106,80;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
108;20682;Current Pharmaceutical Design;journal;13816128;1.2919999999999998;Q1;140;637;1656;76567;6070;1521;3.82;120,20;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
109;23488;Current Medicinal Chemistry;journal;09298673;1.2819999999999998;Q1;158;324;1298;39604;5426;1226;4.35;122,23;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
110;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.276;Q1;33;46;195;880;298;177;1.02;19,13;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
111;24028;Reproductive Toxicology;journal;08906238;1.274;Q1;99;144;422;6832;1597;389;3.91;47,44;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q1)
112;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.267;Q1;40;25;90;1144;366;83;4.23;45,76;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Neurology (Q2)"
113;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.254;Q1;67;22;157;1069;449;151;2.66;48,59;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
114;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.252;Q1;161;254;837;10582;3134;817;3.76;41,66;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
115;25075;Ecotoxicology;journal;09639292, 15733017;1.239;Q1;81;207;580;10174;1792;570;2.99;49,15;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
116;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.239;Q1;61;44;155;2263;479;144;3.31;51,43;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
117;21237;Drug Safety;journal;01145916;1.238;Q1;115;109;325;4634;1081;284;3.75;42,51;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
118;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.231;Q1;52;246;628;5977;1937;609;3.17;24,30;United States;American Chemical Society;2010-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
119;25219;Toxicology;journal;0300483X;1.23;Q1;143;141;652;7379;2564;615;4.02;52,33;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
120;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.222;Q1;63;73;216;2377;602;179;3.36;32,56;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
121;14990;Current Neuropharmacology;journal;1570159X;1.212;Q1;58;44;179;5733;584;168;3.62;130,30;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
122;21165;PharmacoEconomics;journal;11707690;1.203;Q1;91;122;280;5433;745;236;3.06;44,53;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
123;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;1.202;Q1;5;3;1;139;4;1;0.0;46,33;United States;Hindawi Limited;2011, 2014-2015;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Oncology (Q2)"
124;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.198;Q1;99;185;678;6776;2137;573;3.64;36,63;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
125;23015;Journal of Ethnopharmacology;journal;03788741;1.196;Q1;170;698;2072;35827;7985;2036;3.7;51,33;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
126;21100232818;Emerging Microbes and Infections;journal;22221751;1.165;Q1;31;51;71;2986;156;62;2.52;58,55;United Kingdom;Nature Publishing Group;2012-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Parasitology (Q1); Epidemiology (Q2); Immunology (Q2); Infectious Diseases (Q2); Microbiology (Q2); Virology (Q2)"
127;17595;Journal of Biomolecular Screening;journal;10870571;1.155;Q1;69;145;395;4616;957;385;2.46;31,83;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)"
128;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.154;Q1;50;108;286;10590;1008;285;3.8;98,06;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q1)
129;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.149;Q1;104;234;705;18714;2541;624;3.71;79,97;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
130;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.149;Q1;35;62;108;3670;413;105;3.97;59,19;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q1); Pharmacology (Q1)"
131;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.149;Q1;126;266;795;16938;2463;784;3.13;63,68;United States;Elsevier Inc.;1973-ongoing;"Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2)"
132;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.142;Q1;27;40;55;2804;204;54;3.55;70,10;Netherlands;Elsevier BV;2011-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2); Parasitology (Q2)"
133;25240;Toxicology Letters;journal;03784274;1.142;Q1;129;363;900;16919;3418;882;3.66;46,61;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
134;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.141;Q1;100;288;978;8881;3138;946;3.43;30,84;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Toxicology (Q2)"
135;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1.137;Q1;69;15;38;2511;165;38;5.11;167,40;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
136;21100225613;Human gene therapy methods;journal;19466536, 19466544;1.135;Q1;20;35;79;1603;210;79;2.66;45,80;United States;Mary Ann Liebert Inc.;2012-ongoing;"Applied Microbiology and Biotechnology (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3)"
137;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.131;Q1;23;6;18;604;119;18;7.75;100,67;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Nanoscience and Nanotechnology (Q2)"
138;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.114;Q1;54;178;575;11950;1531;451;3.18;67,13;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
139;4400151608;ChemMedChem;journal;18607187, 18607179;1.11;Q1;92;323;699;12324;1948;669;2.81;38,15;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
140;4400151410;Human Vaccines;journal;15548600, 15548619;1.11;Q1;49;0;266;0;740;201;0.0;0,00;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
141;16088;Journal of Nanobiotechnology;journal;14773155;1.109;Q1;57;59;156;2388;754;152;4.63;40,47;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
142;22477;Investigational New Drugs;journal;01676997, 15730646;1.093;Q1;80;147;654;4486;2084;633;3.34;30,52;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
143;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.092;Q1;36;22;82;3347;272;74;4.95;152,14;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
144;4700152848;PPAR Research;journal;16874757, 16874765;1.091;Q1;40;32;139;1330;381;133;2.94;41,56;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
145;17464;European Journal of Medicinal Chemistry;journal;02235234;1.079;Q1;135;930;2002;43180;8205;1993;3.89;46,43;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
146;20473;Life Sciences;journal;00243205;1.074;Q1;150;391;948;17352;2810;928;3.07;44,38;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
147;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.07;Q1;78;196;363;18231;995;314;2.91;93,02;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
148;22432;International Immunopharmacology;journal;15675769;1.061;Q1;98;391;941;16420;2924;915;2.91;41,99;Netherlands;Elsevier BV;2001-ongoing;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
149;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;1.061;Q1;44;56;173;3331;465;165;2.68;59,48;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
150;22411;Inflammopharmacology;journal;09254692, 15685608;1.056;Q2;45;41;115;2219;399;108;4.13;54,12;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (medical) (Q1); Immunology (Q2); Pharmacology (Q2)"
151;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.056;Q1;114;531;1381;18619;4606;1366;3.3;35,06;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Clinical Biochemistry (Q2)"
152;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.054;Q2;78;172;595;5842;1546;576;2.79;33,97;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
153;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.051;Q2;76;77;264;5435;661;259;2.58;70,58;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Psychiatry and Mental Health (Q1); Pharmacology (Q2)"
154;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.051;Q2;39;46;203;1736;561;194;2.96;37,74;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
155;17067;Phytomedicine;journal;09447113;1.043;Q1;105;238;579;7941;2107;568;3.63;33,37;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
156;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;1.042;Q2;95;132;429;5878;1019;367;2.79;44,53;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
157;25096;Food and Chemical Toxicology;journal;02786915;1.038;Q2;149;475;2029;22312;6963;1937;3.43;46,97;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
158;19700175230;Drug Design, Development and Therapy;journal;11778881;1.034;Q1;48;240;234;11056;869;228;3.5;46,07;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
159;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;1.034;Q2;41;77;222;1465;636;181;4.06;19,03;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
160;21333;European Journal of Pharmacology;journal;00142999;1.027;Q2;167;641;2056;30570;6222;2025;2.93;47,69;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
161;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.025;Q1;89;98;302;4819;953;288;3.19;49,17;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
162;20663;Current Drug Metabolism;journal;13892002;1.014;Q2;97;71;332;8760;1122;292;3.52;123,38;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
163;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.01;Q1;142;690;2395;28073;7483;2356;3.1;40,69;United Kingdom;Elsevier Ltd.;1993-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
164;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.008;Q1;119;255;708;12258;2711;695;3.91;48,07;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
165;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;1.007;Q1;37;130;285;6609;650;234;2.58;50,84;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Clinical Biochemistry (Q2)"
166;26767;Altex;journal;1868596X, 18688551;1.006;Q2;45;56;113;2399;379;85;4.49;42,84;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
167;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.005;Q1;73;132;631;10371;1762;573;2.67;78,57;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
168;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.0;Q1;159;425;1336;18314;4352;1256;3.15;43,09;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
169;22983;Journal of Clinical Pharmacology;journal;00912700;0.997;Q2;106;170;563;4396;1537;527;2.93;25,86;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
170;24652;Chemico-Biological Interactions;journal;00092797;0.995;Q2;108;248;558;11164;1663;534;2.96;45,02;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
171;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.994;Q2;7;1;3;23;9;3;3.0;23,00;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
172;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.992;Q2;91;142;486;6654;1166;456;2.4;46,86;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
173;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.991;Q1;80;93;277;4698;880;271;3.21;50,52;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
174;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.986;Q1;61;61;119;2495;354;116;2.71;40,90;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
175;19700188352;Toxins;journal;20726651;0.984;Q2;56;187;361;10016;1181;357;3.24;53,56;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
176;4000151703;Core Evidence;journal;15551741, 1555175X;0.983;Q2;19;15;26;713;106;26;4.21;47,53;United States;Core Medical Pub;2005-ongoing;"Medicine (miscellaneous) (Q1); Reviews and References (medical) (Q1); Pharmacology (Q2)"
177;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.982;Q2;43;41;131;3944;386;126;3.22;96,20;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
178;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.977;Q2;34;82;106;4660;296;102;3.13;56,83;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
179;29712;Clinical Therapeutics;journal;01492918;0.976;Q2;123;233;630;7434;1832;555;3.36;31,91;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;19984;Assay and Drug Development Technologies;journal;1540658X;0.975;Q1;52;63;275;1563;309;139;1.63;24,81;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2)"
181;26512;Tetrahedron;journal;00404020;0.972;Q1;209;1149;3813;58516;11429;3763;2.95;50,93;United Kingdom;Elsevier Ltd.;1957-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
182;22319;Toxicon;journal;00410101;0.972;Q2;116;238;751;10185;2026;727;2.75;42,79;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
183;20027;BMC Pharmacology;journal;14712210;0.968;Q2;38;0;23;0;59;22;4.0;0,00;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;21167;Pharmacogenomics;journal;14622416;0.965;Q2;83;197;615;9357;1585;506;2.97;47,50;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Genetics (Q3)"
185;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.963;Q2;82;144;409;11251;1165;375;2.91;78,13;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Cancer Research (Q3)"
186;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.963;Q2;18;0;3;0;13;3;0.0;0,00;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;19034;Microbial Drug Resistance;journal;10766294;0.959;Q2;62;91;249;3198;689;234;3.12;35,14;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
188;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.949;Q2;74;150;439;6116;1100;437;2.54;40,77;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
189;25224;Toxicology in Vitro;journal;08872333;0.949;Q2;96;183;716;7923;2409;698;3.22;43,30;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
190;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.948;Q2;76;149;370;7893;1204;362;3.29;52,97;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
191;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0.944;Q2;99;83;281;5055;817;276;2.51;60,90;Netherlands;Elsevier BV;2000-ongoing;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
192;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.944;Q2;29;18;60;1928;136;51;2.82;107,11;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
193;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.943;Q2;68;34;132;1411;362;128;2.62;41,50;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
194;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.942;Q1;133;1130;4364;32697;11412;4289;2.69;28,94;United Kingdom;Elsevier Ltd.;1991-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
195;19700194010;MedChemComm;journal;20402503, 20402511;0.942;Q1;44;233;602;10372;1566;578;2.6;44,52;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
196;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.941;Q1;35;80;252;1782;399;199;1.74;22,28;United States;Wiley-Blackwell;2008-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q3)"
197;16573;Phytotherapy Research;journal;10991573, 0951418X;0.94;Q2;112;260;875;10114;2559;868;2.99;38,90;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
198;10900153302;Biomarker Insights;journal;11772719;0.937;Q2;24;13;49;424;129;48;2.71;32,62;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q1); Pharmacology (Q2); Molecular Medicine (Q3)"
199;22410;Inflammation Research;journal;1420908X, 10233830;0.935;Q2;82;128;419;5294;1041;407;2.61;41,36;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
200;21207;Drug Discovery Today: Technologies;journal;17406749;0.928;Q2;41;30;128;1482;332;114;3.1;49,40;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
201;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.924;Q2;43;543;758;21555;1583;574;2.76;39,70;United States;Landes Bioscience;2012-ongoing;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
202;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.912;Q2;98;117;425;6183;1008;420;2.13;52,85;Germany;Springer Verlag;1973-ongoing;"Medicine (miscellaneous) (Q1); Pollution (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
203;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.906;Q2;72;129;378;11853;1232;373;3.32;91,88;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
204;25109;Inhalation Toxicology;journal;08958378, 10917691;0.906;Q2;77;83;302;3973;793;281;2.75;47,87;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
205;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.901;Q2;22;36;39;2605;123;38;3.44;72,36;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
206;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0.9;Q2;83;136;345;5540;853;336;2.54;40,74;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
207;18077;Fitoterapia;journal;0367326X;0.897;Q2;90;259;715;8488;2109;707;2.83;32,77;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
208;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.893;Q1;58;80;239;2458;615;205;3.04;30,73;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
209;25214;Toxicologic Pathology;journal;15331601, 01926233;0.893;Q2;96;120;345;5570;825;324;2.35;46,42;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
210;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.89;Q2;26;34;135;1532;423;131;2.7;45,06;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
211;14805;Steroids;journal;0039128X;0.889;Q2;95;174;599;8241;1727;586;2.91;47,36;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
212;20026;BMC Clinical Pharmacology;journal;14726904;0.883;Q2;35;0;37;0;110;37;3.36;0,00;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
213;20051;BioDrugs;journal;11738804;0.875;Q2;60;53;147;2975;407;144;3.44;56,13;United Kingdom;Adis International Ltd.;1997-ongoing;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
214;24785;Alcohol;journal;07418329;0.873;Q2;74;81;237;4742;606;229;2.59;58,54;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
215;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.87;Q1;32;100;220;6825;543;185;2.74;68,25;United Kingdom;Taylor & Francis;2008-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
216;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.857;Q2;80;125;377;5797;940;367;2.78;46,38;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
217;16533;Phytochemical Analysis;journal;09580344, 10991565;0.846;Q2;63;69;257;2355;756;254;2.74;34,13;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
218;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.833;Q2;64;72;206;2749;517;201;2.7;38,18;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
219;23155;Current Vascular Pharmacology;journal;15701611;0.828;Q2;54;108;276;9714;770;248;2.79;89,94;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
220;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.8240000000000001;Q1;44;167;395;6349;1066;359;2.63;38,02;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
221;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.823;Q2;54;84;292;2796;436;286;1.47;33,29;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
222;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.818;Q1;22;27;73;1290;221;71;2.75;47,78;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
223;4000150314;Chemical Biology and Drug Design;journal;17470277;0.818;-;71;154;544;5480;1468;524;2.67;35,58;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q3)"
224;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0.8170000000000001;Q2;36;19;69;1377;210;68;1.96;72,47;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q1); Plant Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
225;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.8140000000000001;Q2;56;26;99;1323;283;99;3.15;50,88;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
226;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.8140000000000001;Q2;42;43;181;3300;415;163;2.27;76,74;United Arab Emirates;Bentham Science Publishers;2006-2015;"Immunology and Allergy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
227;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.8140000000000001;Q1;12;61;45;475;63;31;2.12;7,79;United Kingdom;BioMed Central;2013-ongoing;"Health Policy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
228;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.8079999999999999;Q2;49;33;133;1828;251;120;1.9;55,39;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
229;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.8079999999999999;Q2;87;26;177;1224;451;168;2.99;47,08;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
230;26514;Tetrahedron Letters;journal;00404039;0.7959999999999999;Q2;159;1646;5090;61149;13396;5037;2.64;37,15;United Kingdom;Elsevier Ltd.;1959-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
231;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.7909999999999999;Q2;53;119;354;4821;692;332;2.01;40,51;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
232;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.79;Q2;50;88;95;4196;225;91;2.4;47,68;United States;Elsevier Inc.;1971-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
233;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.7879999999999999;Q2;78;159;318;5925;778;313;2.41;37,26;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
234;13248;Experimental and Toxicologic Pathology;journal;09402993;0.785;Q2;58;59;378;2572;945;372;2.5;43,59;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
235;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.7829999999999999;Q1;79;170;473;6643;1208;466;2.06;39,08;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
236;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.7829999999999999;Q2;78;201;561;8046;1202;549;2.15;40,03;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
237;144790;Marine Drugs;journal;16603397;0.78;Q2;84;343;676;19326;2650;674;3.25;56,34;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
238;19700175015;Infection and Drug Resistance;journal;11786973;0.777;Q2;27;35;71;2165;175;70;2.36;61,86;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
239;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.774;Q1;104;297;995;9325;2232;970;2.14;31,40;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
240;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.774;Q2;70;90;259;5055;782;255;2.57;56,17;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
241;6400153120;Chinese Medicine;journal;17498546;0.7709999999999999;Q2;34;27;93;1337;263;90;2.04;49,52;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
242;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.769;Q2;79;96;412;8786;1397;393;3.37;91,52;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
243;17700156714;Pharmaceuticals;journal;14248247;0.765;Q1;44;56;242;3813;534;239;2.53;68,09;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q1); Molecular Medicine (Q3)"
244;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.764;Q2;69;252;771;16940;2052;720;3.09;67,22;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.764;Q2;60;216;599;7365;1404;588;2.09;34,10;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
246;21744;Planta Medica;journal;14390221, 00320943;0.762;Q1;103;197;775;6960;1797;737;2.2;35,33;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
247;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.76;Q2;18;0;7;0;20;7;0.0;0,00;United Kingdom;BioMed Central;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
248;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.76;Q2;27;12;76;713;153;69;2.15;59,42;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
249;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.759;Q1;26;36;97;629;194;79;1.97;17,47;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q1)
250;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.758;Q1;21;3;42;314;78;39;0.62;104,67;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q1); Molecular Biology (Q3)"
251;25093;Environmental Toxicology;journal;15227278, 15204081;0.757;Q2;69;147;227;7104;570;225;2.54;48,33;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
252;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.75;Q1;64;263;525;25263;2467;522;5.58;96,06;United States;American Scientific Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
253;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.75;Q2;90;217;450;9398;1145;416;2.54;43,31;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
254;20634;Journal of Texture Studies;journal;00224901;0.748;Q1;48;48;142;1654;277;138;1.62;34,46;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q1); Pharmaceutical Science (Q1)"
255;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.747;Q2;80;154;410;6176;961;384;2.54;40,10;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
256;130063;Pharmacological Reports;journal;17341140, 22995684;0.747;Q2;71;173;493;7293;1193;488;2.31;42,16;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
257;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.7440000000000001;Q2;88;149;403;5846;861;389;2.13;39,23;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
258;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.743;Q1;15;4;24;233;77;23;1.45;58,25;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
259;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.738;Q2;65;111;319;3633;725;316;2.26;32,73;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
260;26370;Molecules;journal;14203049;0.738;Q1;116;1304;2837;60430;8424;2823;2.81;46,34;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
261;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.737;Q2;43;85;259;1696;205;244;0.69;19,95;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
262;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.733;Q2;18;25;58;1291;99;52;1.92;51,64;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q2); Pharmacology (Q2)"
263;20570;Chemotherapy;journal;00093157, 14219794;0.7240000000000001;Q2;49;77;163;2285;340;158;2.36;29,68;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Oncology (Q3)"
264;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.723;Q2;8;42;17;4766;25;13;3.0;113,48;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
265;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.7190000000000001;Q2;77;160;438;7526;834;413;2.17;47,04;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
266;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.7190000000000001;Q2;87;130;353;3576;831;310;2.7;27,51;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
267;22575;Cardiovascular Toxicology;journal;15307905;0.716;Q2;47;38;133;1376;304;126;2.22;36,21;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
268;21100218055;BMC pharmacology & toxicology;journal;20506511;0.715;Q2;23;80;83;2654;193;79;2.44;33,18;United Kingdom;BioMed Central;2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
269;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.711;Q2;53;71;187;2737;418;183;2.28;38,55;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
270;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.711;Q1;107;182;559;7269;1450;552;2.6;39,94;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
271;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.705;Q2;32;53;139;2357;309;134;2.23;44,47;United States;Taylor and Francis;2004-ongoing;"Toxicology (Q2); Immunology (Q3)"
272;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.7;Q2;64;76;243;3202;547;243;2.28;42,13;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
273;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.6990000000000001;Q2;54;56;160;2156;310;151;2.17;38,50;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
274;19700175819;Patient Preference and Adherence;journal;1177889X;0.695;Q1;37;176;290;6644;655;281;2.27;37,75;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
275;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.693;Q2;72;254;507;11259;1282;504;2.45;44,33;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
276;19700200821;Therapeutic delivery;journal;20415990, 20416008;0.6920000000000001;Q1;37;115;415;6787;935;369;2.87;59,02;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q1)
277;19700188217;Bioanalysis;journal;17576180, 17576199;0.6859999999999999;Q1;51;324;939;12404;2122;739;2.85;38,28;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
278;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.6829999999999999;Q2;33;35;92;1437;195;90;2.02;41,06;United Kingdom;BioMed Central;2006-ongoing;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
279;14822;Xenobiotica;journal;00498254, 13665928;0.6809999999999999;Q2;75;120;351;4645;788;343;2.32;38,71;United Kingdom;Taylor & Francis;1971-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
280;21100241601;Toxicology Research;journal;2045452X;0.6779999999999999;Q3;24;66;63;3149;241;59;4.08;47,71;United Kingdom;Royal Society of Chemistry;2012-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
281;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.677;Q2;46;12;49;573;114;46;1.83;47,75;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
282;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.677;Q2;22;19;54;654;83;54;1.58;34,42;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
283;130047;Current Drug Discovery Technologies;journal;15701638;0.6679999999999999;Q2;38;26;106;1787;224;96;1.82;68,73;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
284;19700188360;Pharmaceutics;journal;19994923;0.667;Q1;32;35;121;2168;326;121;2.33;61,94;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q1)
285;20602;Clinical Neuropharmacology;journal;03625664;0.6659999999999999;Q2;74;49;180;1127;429;171;2.61;23,00;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
286;19958;Archives of Pharmacal Research;journal;02536269;0.664;Q2;75;189;697;6523;1673;686;2.45;34,51;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
287;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.6629999999999999;Q3;30;49;115;2205;246;111;2.27;45,00;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
288;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.66;Q2;37;33;68;2056;110;63;1.89;62,30;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
289;20770;Drug Delivery;journal;10717544;0.66;Q1;52;66;166;2705;342;156;2.2;40,98;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
290;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.66;Q3;44;100;340;3016;564;262;2.09;30,16;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
291;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.659;Q2;78;133;372;5311;585;361;1.56;39,93;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Computational Theory and Mathematics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
292;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.652;Q1;69;38;145;2768;371;145;2.34;72,84;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
293;23039;Journal of Liposome Research;journal;08982104, 15322394;0.65;Q1;44;37;112;1425;219;112;2.07;38,51;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
294;15840;Journal of Antibiotics;journal;00218820;0.649;Q2;73;153;391;4468;787;361;1.9;29,20;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
295;19700185200;Journal of Natural Medicines;journal;18610293;0.649;Q1;37;111;318;3265;629;317;2.04;29,41;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
296;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.64;Q1;27;49;145;2119;280;130;1.76;43,24;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science (Q1)
297;23942;Biomedical Chromatography;journal;10990801, 02693879;0.638;Q2;58;242;628;6619;1217;619;1.89;27,35;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3)"
298;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.638;Q2;55;65;277;1879;571;273;2.08;28,91;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
299;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.637;Q1;54;49;150;2036;415;144;2.8;41,55;United States;John Wiley & Sons Inc.;1979-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
300;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.631;Q2;20;23;73;1754;180;70;2.41;76,26;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Endocrinology, Diabetes and Metabolism (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
301;19443;American Journal of Health-System Pharmacy;journal;10792082;0.63;Q2;87;357;1108;5198;1301;608;2.13;14,56;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
302;25898;Journal of Peptide Science;journal;10752617, 10991387;0.625;Q2;60;116;314;5556;576;310;1.67;47,90;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
303;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.623;Q2;22;0;42;0;39;39;0.96;0,00;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q2); Molecular Medicine (Q3)"
304;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.622;Q1;52;187;390;5576;694;369;1.77;29,82;Germany;Springer Verlag;2010-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
305;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.619;Q2;61;133;388;4894;754;378;2.2;36,80;United Kingdom;Taylor & Francis;1985-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
306;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.619;Q1;43;117;111;5592;219;105;2.14;47,79;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
307;25106;Human and Experimental Toxicology;journal;09603271;0.616;Q3;71;132;512;5572;952;495;2.01;42,21;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
308;21194;Pharmacology;journal;00317012, 14230313;0.612;Q2;54;94;256;2636;450;253;1.76;28,04;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
309;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.609;Q2;37;85;195;3256;326;167;1.87;38,31;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
310;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.607;Q2;55;52;132;1692;416;129;3.34;32,54;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
311;5800173383;Current Clinical Pharmacology;journal;15748847;0.603;Q1;33;40;128;2804;237;121;1.85;70,10;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
312;130025;Current Drug Delivery;journal;15672018;0.599;Q2;54;75;212;4622;440;203;1.79;61,63;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q2)
313;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.598;Q2;11;33;124;684;89;121;0.69;20,73;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science (Q2); Statistics and Probability (Q3)"
314;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.595;Q3;63;268;971;6093;1486;970;1.44;22,74;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
315;19700175244;Current Radiopharmaceuticals;journal;18744710;0.589;Q2;21;20;111;651;194;103;1.88;32,55;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2)"
316;29053;Molecular Diversity;journal;1573501X, 13811991;0.588;Q2;54;69;243;3085;568;240;2.02;44,71;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q4)"
317;16067;Reading Teacher;journal;00340561;0.5760000000000001;Q2;44;71;252;1508;224;220;1.16;21,24;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
318;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.574;Q2;70;96;248;3699;493;247;1.76;38,53;United Kingdom;Taylor & Francis;1984-ongoing;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
319;16948;Chirality;journal;1520636X, 08990042;0.5720000000000001;Q2;73;117;418;4208;760;413;1.94;35,97;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Pharmacology (Q3)"
320;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.569;Q3;23;73;202;2839;325;201;1.62;38,89;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q3)"
321;22456;International Journal of Pharmacy Practice;journal;09617671;0.564;Q2;32;68;185;1443;236;162;1.17;21,22;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
322;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.5589999999999999;Q1;32;30;90;1514;163;79;2.07;50,47;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
323;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.5579999999999999;Q3;35;82;265;3883;493;256;1.9;47,35;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
324;21100258853;F1000Research;journal;20461402;0.545;Q1;32;279;255;8784;203;249;0.82;31,48;United Kingdom;F1000 Research Ltd.;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
325;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.545;Q2;53;75;243;2763;423;237;1.69;36,84;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
326;19700201201;EPMA Journal;journal;18785077, 18785085;0.5429999999999999;Q2;26;22;71;1106;147;64;4.5;50,27;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
327;21264;Drugs in R and D;journal;11745886;0.541;Q3;39;39;90;1178;173;85;1.53;30,21;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
328;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.54;Q2;53;224;586;8237;1031;579;1.56;36,77;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
329;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.534;Q3;23;32;99;1286;173;97;1.59;40,19;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
330;13671;Biologicals;journal;10958320, 10451056;0.5329999999999999;Q3;51;49;227;1779;367;220;1.51;36,31;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
331;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.532;Q2;62;90;192;3147;319;187;1.44;34,97;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
332;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.532;Q3;36;26;99;1555;141;92;1.41;59,81;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Pharmacology (Q3)"
333;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.531;Q3;42;54;372;2247;558;346;1.6;41,61;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
334;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.531;Q3;58;115;362;1814;417;331;1.22;15,77;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
335;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.529;Q2;19;8;35;356;78;34;2.0;44,50;United States;Springer Science + Business Media;2010-ongoing;"Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
336;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.529;Q2;33;67;194;1451;193;163;1.32;21,66;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
337;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.528;Q2;54;97;288;3914;529;287;1.78;40,35;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
338;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.526;Q2;33;82;236;2558;411;213;2.04;31,20;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
339;21100239265;PharmaNutrition;journal;22134344;0.525;Q3;14;21;26;829;52;24;2.17;39,48;Netherlands;Elsevier BV;2013-ongoing;"Food Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
340;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.52;Q3;30;40;95;2503;152;88;1.77;62,58;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
341;29947;Journal of Chemotherapy;journal;1120009X;0.518;Q3;45;76;206;1953;336;172;1.96;25,70;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
342;22205;Saudi Pharmaceutical Journal;journal;13190164;0.513;Q2;36;81;136;2545;295;134;2.0;31,42;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
343;24578;Mathematical Medicine and Biology;journal;14778599;0.512;Q3;40;19;56;764;88;54;1.5;40,21;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
344;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.512;Q2;29;144;157;3760;271;148;1.61;26,11;India;Medknow Publications;2008-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
345;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.509;Q2;50;117;316;4033;457;313;1.38;34,47;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
346;19900192900;Molecular Informatics;journal;18681751, 18681743;0.508;Q2;60;73;252;3314;436;239;1.87;45,40;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
347;25171;Mycotoxin Research;journal;01787888;0.508;Q3;31;34;102;1235;160;100;1.34;36,32;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
348;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.4970000000000001;Q1;79;145;512;5001;720;506;1.23;34,49;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
349;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.494;Q3;45;96;515;1996;811;505;1.59;20,79;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
350;19700181240;Global Journal of Pharmacology;journal;19920075;0.493;Q1;13;26;90;847;76;90;0.78;32,58;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
351;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.489;Q2;36;13;68;354;100;65;1.74;27,23;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Cancer Research (Q3); Pharmacology (Q3)"
352;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;0.486;Q3;36;42;21;1801;46;20;2.3;42,88;United Kingdom;BioMed Central;2014-ongoing;"Cancer Research (Q3); Immunology (Q3); Immunology and Allergy (Q3); Molecular Medicine (Q3); Oncology (Q3); Pharmacology (Q3)"
353;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.486;Q1;45;121;383;4676;657;367;1.71;38,64;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
354;19900192163;Results in Pharma Sciences;journal;22112863;0.482;Q2;13;6;27;238;55;27;1.69;39,67;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science (Q2)
355;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.478;Q2;84;181;707;4938;1067;703;1.34;27,28;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
356;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.478;Q2;79;186;736;5203;945;732;1.31;27,97;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
357;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.477;Q3;52;129;356;5212;560;346;1.52;40,40;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
358;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.475;Q3;59;96;271;3538;455;250;1.43;36,85;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
359;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.471;Q3;62;144;385;3824;493;359;1.44;26,56;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
360;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.469;Q2;25;20;63;1585;91;56;1.28;79,25;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
361;17500155003;Records of Natural Products;journal;13076167;0.469;Q3;24;61;158;1453;241;158;1.18;23,82;Turkey;ACG Publications;2009-ongoing;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
362;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0.467;Q3;25;57;139;1649;228;132;1.43;28,93;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
363;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.463;Q2;16;73;68;1532;92;60;1.53;20,99;United States;Wiley-Blackwell;2012-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
364;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.46;Q3;26;70;291;1066;313;166;1.83;15,23;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
365;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0.456;Q1;19;22;85;9;138;85;1.77;0,41;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
366;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.455;Q1;31;187;424;5634;582;411;1.5;30,13;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q3)"
367;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.454;Q3;27;158;307;5538;476;301;1.7;35,05;Iran;University of Medical Sciences;2010-ongoing;"Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
368;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.453;Q3;55;144;347;3619;413;318;1.12;25,13;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
369;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.453;Q3;38;65;195;2553;286;192;1.44;39,28;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
370;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.452;Q3;43;30;96;1316;136;96;1.37;43,87;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
371;23412;Journal of AOAC International;journal;10603271;0.446;Q3;79;233;662;5836;851;647;1.26;25,05;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Environmental Chemistry (Q3); Pharmacology (Q3)"
372;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.442;Q3;51;73;214;3093;295;197;1.58;42,37;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
373;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.441;Q3;26;66;221;2397;321;221;1.92;36,32;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Biochemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
374;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.439;Q2;34;61;214;1526;354;211;1.41;25,02;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
375;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0.4370000000000001;Q1;22;38;149;670;175;132;1.33;17,63;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
376;19700174889;Drug Target Insights;journal;11773928;0.435;Q1;10;7;12;311;22;12;2.1;44,43;New Zealand;Libertas Academica;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
377;21717;Die Pharmazie;journal;00317144;0.433;Q2;56;169;519;4656;695;519;1.25;27,55;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
378;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.431;Q3;21;27;68;1907;114;65;1.86;70,63;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
379;21256;Drugs of Today;journal;16993993, 16994019;0.4270000000000001;Q3;46;68;220;2346;332;213;1.6;34,50;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
380;21100238633;BioImpacts;journal;22285652, 22285660;0.426;Q2;24;31;94;1236;169;85;2.04;39,87;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
381;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.424;Q2;26;380;1053;9649;884;1052;0.85;25,39;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
382;5800173386;Current Drug Safety;journal;15748863;0.424;Q3;31;35;173;1681;258;161;1.39;48,03;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
383;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.423;Q1;52;211;724;3821;884;615;1.39;18,11;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
384;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.42;Q3;34;40;116;1090;181;115;1.61;27,25;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
385;4700152603;Medicinal Chemistry;journal;15734064;0.42;Q3;39;86;338;3856;500;329;1.4;44,84;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
386;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.415;Q3;42;54;139;2447;224;135;1.68;45,31;United Kingdom;Taylor & Francis;1993-ongoing;"Bioengineering (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
387;18384;Medicinal Chemistry Research;journal;10542523;0.412;Q2;38;485;1306;16160;2064;1298;1.58;33,32;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
388;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.411;Q3;27;139;280;4327;391;280;1.5;31,13;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
389;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.411;Q3;25;13;78;288;110;73;1.27;22,15;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
390;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.41;Q3;54;38;156;1615;189;148;0.84;42,50;United States;John Wiley & Sons Inc.;2003-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4); Embryology (Q4)"
391;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.408;Q2;35;172;516;2955;575;516;1.07;17,18;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
392;20580;Journal of Food Biochemistry;journal;01458884;0.408;Q3;40;68;311;2721;340;311;0.99;40,01;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
393;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.407;Q2;47;0;931;0;1326;931;2.0;0,00;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
394;27210;In Vivo;journal;0258851X;0.406;Q3;54;172;425;4676;508;410;1.14;27,19;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
395;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.405;Q3;21;54;146;1614;149;144;0.91;29,89;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
396;19398;Acta Pharmaceutica;journal;13300075;0.402;Q2;49;40;120;1080;183;120;1.24;27,00;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
397;25864;Heterocycles;journal;03855414;0.398;Q3;61;270;730;10787;826;725;1.19;39,95;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
398;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.397;Q2;27;97;335;2278;430;280;1.12;23,48;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
399;18800156720;Dissolution Technologies;journal;1521298X;0.395;Q2;28;32;92;580;109;76;0.8;18,13;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
400;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.392;Q3;29;51;280;2757;282;277;0.97;54,06;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q3)
401;4500151530;Personalized Medicine;journal;17410541;0.389;Q3;24;79;276;3908;313;231;1.26;49,47;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
402;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.387;Q2;20;51;79;1763;125;79;1.67;34,57;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
403;130031;Journal of Toxicologic Pathology;journal;09149198;0.382;Q3;20;32;127;1176;112;125;0.73;36,75;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
404;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0.38;Q2;11;51;164;1076;68;141;0.52;21,10;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Business and International Management (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Decision Sciences (miscellaneous) (Q3)"
405;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.38;Q3;24;36;113;1849;172;101;1.34;51,36;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
406;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.38;Q2;21;47;179;1569;211;179;1.13;33,38;China;Xi'an Jiaotong University;2014-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Electrochemistry (Q3); Spectroscopy (Q3)"
407;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.379;Q3;52;150;569;2719;665;455;1.28;18,13;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
408;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.374;Q3;5;0;10;0;13;10;0.0;0,00;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
409;144963;Drug Discovery Today: Disease Models;journal;17406757;0.373;Q3;23;27;90;1298;62;81;0.45;48,07;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
410;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.3720000000000001;Q3;41;115;319;3812;328;314;1.14;33,15;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
411;17700155034;Natural product communications;journal;15559475, 1934578X;0.371;Q3;35;458;1311;10867;1405;1283;1.08;23,73;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
412;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.369;Q3;19;102;132;2698;181;132;1.44;26,45;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
413;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.369;Q3;25;56;174;1811;227;172;1.36;32,34;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
414;21100318814;Pharmaceutical patent analyst;journal;20468962;0.368;Q2;13;58;75;388;44;44;1.0;6,69;United Kingdom;Future Science;2012-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
415;21100469670;Antibiotics;journal;20796382;0.365;Q2;20;41;37;2586;53;36;1.47;63,07;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Infectious Diseases (Q3); Microbiology (Q3); Microbiology (medical) (Q3); Pharmacology (medical) (Q3)"
416;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.363;Q2;35;309;409;7177;453;409;0.97;23,23;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
417;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.359;Q3;12;24;77;751;55;70;0.74;31,29;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q3); Drug Discovery (Q3)"
418;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.354;Q3;26;41;188;1686;232;179;1.23;41,12;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
419;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.35200000000000004;Q2;25;171;528;2557;412;299;1.4;14,95;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
420;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.35;Q2;35;133;434;3756;497;429;1.01;28,24;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
421;4700152612;Current Nanoscience;journal;15734137;0.35;Q2;37;136;396;3897;499;387;1.22;28,65;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
422;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.348;Q2;50;87;347;2341;344;343;0.86;26,91;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
423;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0.348;Q2;18;51;152;1900;175;150;1.35;37,25;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
424;35190;Revista Espanola de Quimioterapia;journal;02143429;0.34600000000000003;Q3;23;48;160;1311;153;119;1.22;27,31;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
425;144879;Toxicology International;journal;09716580;0.342;Q3;21;60;136;1606;158;131;1.1;26,77;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
426;21100219314;Applied and Translational Genomics;journal;22120661;0.341;Q2;13;33;21;600;12;18;0.67;18,18;Netherlands;Elsevier BV;2012-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3); Molecular Biology (Q4)"
427;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.341;Q2;17;46;44;2307;45;43;1.05;50,15;Egypt;Hindawi Publishing Corporation;2013-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Genetics (Q4); Molecular Biology (Q4)"
428;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.34;Q3;26;0;72;0;65;67;0.97;0,00;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
429;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.34;Q2;9;12;30;359;31;30;1.06;29,92;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science (Q2)
430;19300156901;Dose-Response;journal;15593258;0.339;Q3;30;41;126;2841;209;123;1.6;69,29;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
431;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.338;Q3;18;12;47;323;53;46;1.13;26,92;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
432;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.337;Q3;40;165;458;5189;450;457;0.79;31,45;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
433;19600162009;Advances in Molecular Toxicology;book series;18720854;0.334;Q3;10;7;22;1014;32;13;2.29;144,86;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
434;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.332;Q3;23;142;276;4566;156;271;0.48;32,15;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
435;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;0.33;Q2;6;0;19;0;21;10;0.0;0,00;India;Medknow Publications;2011;Pharmaceutical Science (Q2)
436;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.329;Q3;23;55;226;3524;152;223;0.61;64,07;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
437;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0.329;Q2;29;2088;2087;30851;1853;2087;0.87;14,78;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q2)
438;19700174961;BioProcess International;trade journal;15426319;0.328;Q3;20;159;453;947;214;427;0.51;5,96;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
439;16836;BMC Chemical Biology;journal;14726769;0.328;Q3;19;0;7;0;9;7;1.8;0,00;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q3); Molecular Medicine (Q4)"
440;19700200880;Botulinum Journal;journal;17547326;0.327;Q2;5;0;21;0;16;19;0.54;0,00;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Cellular and Molecular Neuroscience (Q4)"
441;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.325;Q3;19;44;138;843;112;112;0.83;19,16;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
442;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.325;Q2;13;24;42;892;31;31;1.19;37,17;United States;IPEC-Americas;2010-ongoing;"Pharmaceutical Science (Q2); Food Science (Q3)"
443;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.32299999999999995;Q3;30;62;126;2334;132;123;1.01;37,65;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
444;19700174969;Archives of Drug Information;journal;17535174;0.32;Q2;10;0;4;0;8;4;0.0;0,00;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
445;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.32;Q3;22;0;23;0;40;23;0.0;0,00;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q3)
446;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0.318;Q3;18;11;67;404;53;67;0.55;36,73;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q3)
447;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.316;Q2;37;1545;2772;41650;1981;2770;0.64;26,96;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
448;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.315;Q2;37;88;476;3758;558;463;1.16;42,70;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
449;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.312;Q3;12;34;106;1137;105;104;1.13;33,44;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
450;21192;Drug Development Research;journal;02724391, 10982299;0.311;Q3;54;77;211;2588;180;208;0.89;33,61;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
451;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.307;Q2;16;51;95;1586;82;94;0.87;31,10;Netherlands;Springer Netherlands;2012-ongoing;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
452;145693;Canadian Pharmacists Journal;journal;17151635;0.306;Q2;18;58;316;909;95;140;0.69;15,67;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
453;11200153563;Drug Metabolism Letters;journal;18723128;0.306;Q2;23;17;92;483;98;90;0.94;28,41;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
454;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.305;Q3;30;56;98;2254;95;96;1.21;40,25;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
455;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.305;Q2;25;40;72;1286;83;70;1.21;32,15;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
456;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.304;Q2;40;279;789;6705;598;789;0.58;24,03;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
457;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.303;Q2;19;18;50;507;55;50;0.94;28,17;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
458;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;0.302;Q2;19;18;117;725;133;87;1.66;40,28;India;OMICS Publishing Group;2010-2014 (cancelled);"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
459;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.3;Q3;58;35;120;1014;104;98;1.27;28,97;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
460;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.299;Q2;17;14;50;521;43;50;0.55;37,21;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q4)"
461;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.298;Q2;35;59;179;2000;194;174;1.12;33,90;United States;Informa Healthcare;2013-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
462;19383;Fluoride - Quarterly Reports;journal;00154725;0.298;Q3;41;33;113;965;66;102;0.68;29,24;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4)"
463;19500156813;Procedia in Vaccinology;journal;1877282X;0.298;Q2;10;0;64;0;42;64;0.62;0,00;Netherlands;Elsevier BV;2009-2012;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Immunology (Q4)"
464;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.297;Q3;12;11;64;422;77;64;0.52;38,36;United States;Academic Journals Inc.;2009-2016 (cancelled);"Pollution (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
465;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.29600000000000004;Q2;27;61;93;2478;79;93;0.95;40,62;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
466;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.29600000000000004;Q4;25;76;209;1668;225;203;1.25;21,95;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
467;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.295;Q3;30;2;22;56;14;22;0.57;28,00;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
468;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.295;Q2;46;224;640;5583;534;636;0.72;24,92;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
469;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.293;Q4;55;66;209;1399;172;157;1.06;21,20;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
470;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.292;Q2;25;0;409;0;361;409;0.0;0,00;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
471;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.292;Q2;17;59;173;1249;155;173;0.51;21,17;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
472;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.29100000000000004;Q2;23;90;134;2782;165;134;1.3;30,91;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
473;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;0.28600000000000003;Q2;7;0;26;0;20;26;0.0;0,00;Bangladesh;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science (Q2)
474;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.284;Q2;19;37;101;1112;78;99;0.92;30,05;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
475;19700200724;Der Pharmacia Lettre;journal;09755071;0.28300000000000003;Q2;24;280;807;6038;463;807;0.51;21,56;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science (Q2)
476;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.282;Q2;14;23;91;935;71;78;0.98;40,65;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuroscience (miscellaneous) (Q3); Neuropsychology and Physiological Psychology (Q4)"
477;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.281;Q2;28;249;1117;7263;730;1115;0.54;29,17;India;MediPoeia;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
478;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.281;Q3;18;271;772;6676;421;771;0.59;24,63;India;Scientific Publishers;2008-ongoing;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
479;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.28;Q2;8;0;66;0;50;66;0.76;0,00;India;R R College of Pharmacy;2010, 2012-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
480;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.274;Q3;19;24;100;910;92;88;1.52;37,92;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
481;19700175758;International Journal of Drug Development and Research;journal;09759344;0.274;Q2;17;103;540;2618;292;538;0.45;25,42;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
482;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.274;Q3;18;45;180;1626;102;177;0.51;36,13;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
483;19700188355;International Journal of Phytomedicine;journal;09750185;0.27;Q3;15;66;206;2118;127;206;0.28;32,09;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
484;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.266;Q4;22;55;146;1779;125;134;0.85;32,35;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
485;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.264;Q2;15;12;113;416;81;113;0.36;34,67;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
486;21100470510;Drug Research;journal;21949379, 21949387;0.262;Q3;56;188;398;4401;299;386;0.81;23,41;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
487;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.262;Q4;18;147;405;2059;34;405;0.08;14,01;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q2); Pathology and Forensic Medicine (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
488;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.262;Q2;20;55;16;2210;14;16;0.88;40,18;United Kingdom;Wiley-Blackwell Publishing Ltd;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (Q3)"
489;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;0.261;Q3;14;190;120;4938;57;120;0.36;25,99;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery (Q3)
490;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.26;Q3;29;292;383;6133;347;381;0.82;21,00;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
491;21810;Farmacia;journal;00148237;0.259;Q2;19;100;326;2221;255;324;0.85;22,21;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
492;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.256;Q3;10;31;80;563;36;79;0.48;18,16;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
493;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.256;Q4;38;9;137;508;80;122;0.75;56,44;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q4); Toxicology (Q4)"
494;73430;Pharmaceutical Technology;journal;15432521;0.255;Q3;35;167;612;530;85;553;0.17;3,17;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q3); Biophysics (Q4)"
495;19700175096;Pharmacognosy Journal;journal;09753575;0.255;Q3;14;103;280;2977;172;273;0.69;28,90;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
496;20578;Journal of Food and Drug Analysis;journal;10219498;0.253;Q3;41;67;305;2982;211;295;0.68;44,51;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
497;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.251;Q3;38;105;213;3996;152;204;0.56;38,06;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q3)
498;21100196907;Open Toxinology Journal;journal;18754147;0.25;Q4;2;0;2;0;4;2;0.0;0,00;United Arab Emirates;Bentham Science Publishers;2011-2013;"Pharmacology (medical) (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
499;130089;Toxin Reviews;journal;15569543, 15569551;0.249;Q4;38;28;30;1686;30;29;0.76;60,21;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q4)
500;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.247;Q2;26;35;68;1696;122;67;1.59;48,46;Spain;Elsevier Espana;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
501;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.246;Q3;36;167;351;2055;380;346;0.83;12,31;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
502;5800173401;Current Bioactive Compounds;journal;15734072;0.246;Q2;21;29;103;1736;86;91;0.77;59,86;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
503;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.246;Q3;15;21;62;453;51;57;0.61;21,57;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
504;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.245;Q3;7;0;18;0;12;18;0.43;0,00;United Kingdom;Inderscience Publishers;2010-2012;"Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
505;80593;Journal of Medicinal Plants;journal;16840240;0.245;Q3;16;50;196;1568;100;196;0.39;31,36;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
506;17700156303;Neuromethods;book series;19406045, 08932336;0.244;Q2;17;142;546;7881;202;490;0.35;55,50;United States;Humana Press, Inc.;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
507;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.243;Q3;22;36;129;1263;102;127;0.83;35,08;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
508;19700170617;EXCLI Journal;journal;16112156;0.242;Q3;24;108;220;6099;243;188;1.3;56,47;Germany;University of Mainz;2009-ongoing;"Drug Discovery (Q3); Pharmacology (Q3); Animal Science and Zoology (Q4); Molecular Medicine (Q4)"
509;130038;Letters in Drug Design and Discovery;journal;15701808;0.241;Q3;28;135;394;4348;301;388;0.85;32,21;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
510;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.238;Q3;22;49;141;1641;112;124;0.79;33,49;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
511;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.237;Q2;14;118;185;2337;87;170;0.45;19,81;Netherlands;Elsevier BV;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
512;19700188484;Journal of Bioequivalence and Bioavailability;journal;09750851;0.237;Q3;10;30;148;993;61;120;0.48;33,10;India;OMICS Publishing Group;2011-2014 (cancelled);Pharmaceutical Science (Q3)
513;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0.235;Q2;15;50;271;1114;110;271;0.38;22,28;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
514;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;0.235;Q3;9;3;80;66;47;59;0.48;22,00;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science (Q3)
515;23489;Chemical Speciation and Bioavailability;journal;09542299;0.231;Q4;25;35;96;1334;63;95;0.75;38,11;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
516;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.231;Q3;45;79;183;1757;116;161;0.68;22,24;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
517;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.231;Q2;12;34;107;1011;66;95;0.73;29,74;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
518;19700201609;Open Natural Products Journal;journal;18748481;0.231;Q3;3;1;9;67;9;9;0.83;67,00;Netherlands;Bentham Science Publishers B.V.;2011-2014;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3)"
519;19446;American Pharmaceutical Review;journal;10998012;0.23;Q3;20;71;225;900;91;211;0.41;12,68;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
520;5800179590;Pharmacologyonline;journal;18278620;0.227;Q3;21;72;530;2273;237;529;0.28;31,57;Italy;SILAE;2007-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
521;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.226;Q2;43;115;348;3366;230;347;0.53;29,27;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
522;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;0.226;Q3;11;0;94;0;67;93;0.7;0,00;United States;Taylor and Francis;2009-2012;"Biomedical Engineering (Q3); Pharmaceutical Science (Q3); Nanoscience and Nanotechnology (Q4)"
523;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.225;Q3;12;7;62;416;58;60;0.5;59,43;Pakistan;ANSInet;2009-2016 (cancelled);"Pharmacology (Q3); Biochemistry (Q4)"
524;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.225;Q4;6;26;85;349;14;76;0.12;13,42;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
525;21758;Prescrire International;journal;11677422;0.225;Q3;11;186;623;1270;126;579;0.22;6,83;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
526;15340;Developments in Biologicals;book series;14246074;0.224;Q3;35;0;42;0;21;41;0.51;0,00;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
527;19200156925;Cancer Therapy;journal;15439143, 15439135;0.221;Q3;8;4;14;408;19;14;0.18;102,00;United States;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
528;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.22;Q3;17;16;109;867;80;86;0.75;54,19;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
529;23171;Korean Journal of Pharmacognosy;journal;02533073;0.22;Q3;14;55;92;1442;54;92;0.59;26,22;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
530;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.22;Q2;18;67;279;1235;105;278;0.23;18,43;India;Rasayan Journal;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
531;19700201333;International Journal of Drug Delivery;journal;09750215;0.219;Q3;11;40;141;1284;75;141;0.2;32,10;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science (Q3)
532;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.219;Q3;26;168;476;2927;225;427;0.46;17,42;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
533;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.219;Q3;29;256;786;6678;476;786;0.62;26,09;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
534;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.217;Q3;20;90;253;2058;107;253;0.3;22,87;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
535;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.21600000000000005;Q3;15;30;104;914;30;86;0.41;30,47;United States;SAGE Publications Inc.;2000-ongoing;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
536;13718;Pharmaceutical Engineering;journal;02738139;0.21600000000000005;Q3;13;67;174;529;27;151;0.17;7,90;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
537;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.215;Q3;34;45;78;1501;61;73;0.94;33,36;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
538;144613;Journal of Generic Medicines;journal;17411343;0.213;Q3;14;28;93;219;25;83;0.25;7,82;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
539;4700152607;Current Enzyme Inhibition;journal;15734080;0.212;Q4;15;16;55;683;27;49;0.52;42,69;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
540;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.212;Q3;24;35;102;998;66;101;0.53;28,51;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
541;21100244805;Journal of Vaccines and Vaccination;journal;21577560;0.211;Q4;9;31;126;1090;40;105;0.37;35,16;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
542;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.21;Q3;8;16;34;1045;24;34;0.29;65,31;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
543;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0.209;Q3;24;638;1214;19592;451;1213;0.29;30,71;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q3)
544;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.206;Q3;14;18;94;683;43;88;0.37;37,94;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
545;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.203;Q3;16;56;186;1935;99;173;0.55;34,55;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
546;21811;Farmacia Hospitalaria;journal;11306343;0.203;Q3;21;91;306;1254;110;202;0.49;13,78;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
547;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.202;Q3;16;37;101;1254;45;98;0.45;33,89;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
548;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.201;Q3;9;7;33;411;13;28;0.44;58,71;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
549;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.2;Q3;32;101;284;3459;144;274;0.42;34,25;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
550;25144;Journal of Health Science;journal;13475207, 13449702;0.2;Q4;42;0;70;0;52;63;0.0;0,00;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
551;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.199;Q3;10;113;234;2828;116;232;0.42;25,03;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science (Q3)
552;110097;Food and Drug Law Journal;journal;1064590X;0.197;Q3;18;25;69;0;23;68;0.37;0,00;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q4)"
553;21265;Drugs of the Future;journal;03778282;0.196;Q3;40;120;336;2567;115;329;0.26;21,39;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
554;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.195;Q3;7;10;9;1155;6;8;0.5;115,50;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
555;19700174658;Regulatory Rapporteur;trade journal;17428955;0.195;Q3;5;74;214;449;21;174;0.1;6,07;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacy (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
556;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.194;Q3;6;0;6;0;4;6;0.0;0,00;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
557;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.194;Q3;17;270;687;1745;51;667;0.07;6,46;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
558;21100202909;Drug Invention Today;journal;09757619;0.193;Q4;12;3;145;98;74;144;0.51;32,67;India;Association of Pharmaceutical Innovators;2012-ongoing;Drug Discovery (Q4)
559;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.193;Q3;12;70;109;2150;71;95;0.75;30,71;United States;Elsevier USA;2012-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q3); Health Policy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
560;19700170837;Vitae;journal;01214004;0.193;Q3;11;82;134;1172;41;72;0.28;14,29;Colombia;Universidad de Antioquia;2009-ongoing;"Food Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4)"
561;58808;Pharmaceutical Care and Research;journal;16712838;0.192;Q3;7;166;469;1318;56;468;0.11;7,94;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
562;25197;Revista de Toxicologia;journal;16970748, 02127113;0.192;Q4;9;9;51;383;9;49;0.14;42,56;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
563;15600154705;EnvironmentAsia;journal;19061714;0.191;Q4;14;35;65;937;30;65;0.33;26,77;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
564;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.191;Q3;13;130;100;8468;53;100;0.53;65,14;United Kingdom;Taylor & Francis;2013-ongoing;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
565;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.191;Q3;8;68;158;1250;24;147;0.11;18,38;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
566;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;0.19;Q3;8;28;46;678;17;46;0.43;24,21;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
567;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.19;Q3;8;43;100;1263;23;88;0.25;29,37;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
568;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.19;Q4;33;46;69;5657;48;37;1.3;122,98;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
569;21083;Pharmaceutical Care Espana;journal;11396202;0.189;Q3;9;45;94;463;13;69;0.14;10,29;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q4)"
570;22854;Yakugaku Zasshi;journal;00316903;0.189;Q3;37;186;475;3686;184;423;0.32;19,82;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
571;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.188;Q3;21;0;0;0;0;0;0.0;0,00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
572;21798;Farmaceutski Glasnik;journal;00148202;0.188;Q3;5;81;210;723;9;172;0.06;8,93;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
573;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.188;Q3;11;42;100;1033;47;100;0.47;24,60;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
574;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q4;5;151;435;553;7;383;0.02;3,66;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
575;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.18600000000000005;Q3;14;5;36;207;7;30;0.13;41,40;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
576;24071;Metal-Based Drugs;journal;07930291, 16875486;0.18600000000000005;Q4;33;0;1;0;2;1;0.0;0,00;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q4); Inorganic Chemistry (Q4); Pharmacology (Q4); Toxicology (Q4)"
577;19700175040;Open Vaccine Journal;journal;18750354;0.183;Q3;9;0;10;0;8;8;0.6;0,00;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
578;21100197929;Toxicological Research;journal;19768257;0.183;Q4;20;42;152;1452;69;152;0.49;34,57;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
579;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;0.182;Q4;9;22;67;782;38;67;0.41;35,55;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery (Q4)
580;21100293201;International Journal of Research in Ayurveda and Pharmacy;journal;22774343, 22293566;0.179;Q3;8;118;397;2619;77;397;0.19;22,19;India;Moksha Publishing House;2012-2016 (cancelled);"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
581;21100223537;European Journal of Hospital Pharmacy: Science and Practice;journal;20479956, 20479964;0.17800000000000002;Q3;11;100;243;1502;66;127;0.52;15,02;Belgium;European Association of Hospital Pharmacists (EAHP);2012-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
582;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.17800000000000002;Q4;2;0;3;0;3;3;0.5;0,00;India;Open Access Science Research Publisher;2013;"Drug Discovery (Q4); Plant Science (Q4)"
583;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.174;Q3;15;0;37;0;16;37;0.0;0,00;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q3)
584;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.174;Q4;21;21;42;1038;20;40;0.5;49,43;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4)"
585;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.173;Q3;15;37;76;899;39;70;0.54;24,30;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
586;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.173;Q4;8;13;30;650;9;15;0.6;50,00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
587;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0.173;Q3;11;3;31;58;17;30;0.21;19,33;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q3)
588;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.172;Q3;15;10;36;877;28;21;1.64;87,70;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
589;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.172;Q4;11;51;151;1408;47;145;0.32;27,61;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
590;19700174940;SA Pharmaceutical Journal;journal;10151362;0.172;Q3;6;89;436;496;22;244;0.06;5,57;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q3)
591;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.171;Q4;7;58;376;1105;47;376;0.1;19,05;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
592;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0.171;Q3;9;11;45;235;21;45;0.27;21,36;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q3)
593;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.171;Q3;5;20;5;784;7;4;1.75;39,20;Chile;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
594;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;0.16899999999999998;Q3;9;64;63;1914;27;63;0.27;29,91;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
595;79053;Natural Product Sciences;journal;12263907;0.168;Q4;22;53;163;1232;50;163;0.2;23,25;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
596;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;0.16699999999999998;Q3;15;81;494;1904;118;493;0.2;23,51;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
597;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.16699999999999998;Q3;6;62;45;2229;9;42;0.21;35,95;United States;Humana Press, Inc.;2008, 2012-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
598;21100451405;Natural Products Journal;journal;22103163, 22103155;0.16699999999999998;Q4;9;40;97;1595;42;92;0.48;39,88;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
599;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.16699999999999998;Q3;26;918;2398;8941;724;2397;0.28;9,74;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
600;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;0.166;Q3;8;9;50;264;22;50;0.17;29,33;Turkey;Moment Publications;2011-ongoing;"Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
601;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.165;Q4;8;37;31;1001;16;31;0.52;27,05;Italy;Scuola IaD;2015-ongoing;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
602;9800153137;Trastornos Adictivos;journal;15750973;0.165;Q4;8;0;45;0;11;37;0.31;0,00;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
603;21100301409;Issues in Toxicology;book series;17577179;0.16399999999999998;Q4;12;54;126;4628;30;116;0.28;85,70;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
604;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.16399999999999998;Q4;16;27;68;834;30;68;0.56;30,89;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
605;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0.16399999999999998;Q3;24;1227;1705;26940;435;1705;0.21;21,96;India;RJPBCS;2010-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
606;20065;BioPharm International;journal;1542166X;0.162;Q3;25;97;389;320;68;361;0.15;3,30;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
607;22934;Chinese Pharmaceutical Journal;journal;10012494;0.162;Q3;19;448;1429;7052;311;1429;0.2;15,74;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
608;19700175149;African Journal Biomedical Research;journal;11195096;0.161;Q3;15;30;92;760;26;91;0.16;25,33;Nigeria;Bioline International;2008, 2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
609;4700152278;Drugs in Context;journal;17404398, 17451981;0.161;Q4;12;7;16;361;13;14;0.93;51,57;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
610;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.16;Q4;18;8;35;198;13;35;0.32;24,75;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
611;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.159;Q3;10;47;148;1596;55;148;0.28;33,96;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
612;21800;Farmacevtski Vestnik;journal;00148229;0.159;Q3;4;56;157;978;5;145;0.02;17,46;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q4)"
613;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;0.159;Q4;6;12;40;483;15;39;0.38;40,25;United Kingdom;Internet Medical Publishing;2011-2015;"Pharmacology (medical) (Q3); Microbiology (medical) (Q4); Pharmacology (Q4)"
614;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.159;Q3;7;3;54;117;30;54;0.35;39,00;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science (Q3)
615;22908;Chinese Pharmacological Bulletin;journal;10011978;0.157;Q4;15;397;1276;6663;402;1276;0.32;16,78;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q4)
616;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.157;Q3;12;100;215;2003;40;186;0.28;20,03;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4)"
617;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.156;Q4;18;98;421;619;118;275;0.77;6,32;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
618;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.155;Q3;16;21;66;775;30;66;0.55;36,90;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
619;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.155;Q3;8;19;70;570;21;70;0.23;30,00;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q3)
620;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.155;Q3;3;0;8;0;3;8;0.33;0,00;Netherlands;Bentham Science Publishers B.V.;2011-2013;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
621;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.155;Q3;14;253;955;6296;142;955;0.18;24,89;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
622;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.154;Q3;7;9;39;344;12;38;0.22;38,22;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
623;5800173394;Current Drug Therapy;journal;15748855;0.154;Q3;14;23;91;1402;39;85;0.33;60,96;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
624;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.152;Q3;6;4;79;348;28;79;0.51;87,00;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
625;21100804474;European Pharmaceutical Journal;journal;24536725;0.151;Q3;5;12;61;320;11;60;0.2;26,67;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
626;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.151;Q3;10;25;77;793;27;77;0.36;31,72;Turkey;Marmara University;2010-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
627;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;0.15;Q3;7;63;79;1091;22;70;0.32;17,32;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
628;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.15;Q4;5;36;86;770;24;78;0.35;21,39;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
629;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.149;Q3;14;86;206;3070;61;206;0.28;35,70;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
630;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.14800000000000002;Q4;9;19;135;488;28;128;0.19;25,68;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
631;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.14800000000000002;Q3;5;13;37;249;8;34;0.42;19,15;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
632;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.14800000000000002;Q3;3;0;12;0;4;11;0.57;0,00;New Zealand;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
633;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.14800000000000002;Q4;9;45;147;1654;38;145;0.31;36,76;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
634;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.147;Q3;3;36;101;710;6;100;0.07;19,72;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
635;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254;0.146;Q4;5;0;53;0;16;52;0.26;0,00;Taiwan;Elsevier Taiwan;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
636;19700200708;Journal of Global Pharma Technology;journal;09758542;0.146;Q3;10;6;96;114;23;96;0.17;19,00;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q3)
637;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0.146;Q4;8;34;80;964;27;80;0.23;28,35;Canada;Lifescience Global;2011-ongoing;"Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
638;19700201410;Milestones in Drug Therapy;book series;22966056;0.146;Q3;4;1;100;23;16;94;0.21;23,00;United States;Springer Science + Business Media;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)"
639;5200152604;Pharma Times;journal;00316849;0.146;Q4;10;83;232;546;26;146;0.16;6,58;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
640;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.145;Q3;9;37;96;164;8;92;0.11;4,43;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
641;17600155051;Drug Delivery Technology;trade journal;15372898;0.14400000000000002;Q3;9;97;243;280;16;131;0.18;2,89;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q3)
642;73076;Drug Discovery World;journal;14694344;0.14400000000000002;Q4;10;39;125;385;30;111;0.19;9,87;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
643;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0.14300000000000002;Q4;5;13;70;142;15;55;0.24;10,92;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
644;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.142;Q4;13;106;364;1160;62;363;0.15;10,94;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
645;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0.142;Q4;11;167;117;1864;18;117;0.17;11,16;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
646;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.14;Q4;15;39;128;1191;28;121;0.24;30,54;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q4)
647;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.14;Q4;4;16;90;584;5;87;0.08;36,50;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
648;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.14;Q4;6;3;11;80;3;10;0.5;26,67;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
649;21211;Pharmacy Education;journal;14772701, 15602214;0.139;Q4;15;22;68;453;16;68;0.31;20,59;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
650;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.138;Q4;5;22;42;641;12;41;0.29;29,14;Iran;Kermanshah University of Medical Sciences;2012-ongoing;"Biomedical Engineering (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
651;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.13699999999999998;Q4;11;20;53;69;11;53;0.16;3,45;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
652;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.135;Q4;13;655;1757;9826;320;1606;0.2;15,00;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
653;22338;Hospital Pharmacy;journal;00185787;0.135;Q4;21;157;421;2786;70;377;0.22;17,75;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
654;19700175049;Internet Journal of Toxicology;journal;15593916;0.135;Q4;5;0;9;0;3;9;0.17;0,00;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
655;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.135;Q4;9;0;59;0;14;59;0.16;0,00;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
656;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.135;Q4;8;45;130;1134;23;130;0.16;25,20;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
657;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.134;Q4;12;18;49;371;9;48;0.13;20,61;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
658;21100228007;Archives of Razi Institute;journal;03653439;0.134;Q4;5;28;48;757;13;48;0.27;27,04;Iran;Razi Vaccine and Serum Research Institute;2012-ongoing;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
659;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.133;Q4;12;26;81;761;20;81;0.2;29,27;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
660;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.133;Q4;12;49;171;811;8;127;0.09;16,55;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
661;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0.132;Q4;10;0;29;0;6;26;0.23;0,00;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
662;19700175137;Trends in Medical Research;journal;18193587;0.132;Q4;8;9;26;325;14;26;0.42;36,11;United States;Academic Journals Inc.;2008-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
663;15842;Journal of Applied Research;journal;1537064X;0.131;Q4;18;4;26;102;10;26;0.47;25,50;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
664;22375;Indian Drugs;journal;0019462X;0.13;Q4;30;73;262;1808;31;262;0.11;24,77;India;Scientific Publishers;1989-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
665;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.13;Q4;9;40;79;920;19;78;0.2;23,00;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
666;22514;Japanese Journal of Chemotherapy;journal;13407007;0.13;Q4;12;19;85;384;14;85;0.09;20,21;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
667;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.13;Q4;7;0;9;0;3;8;0.0;0,00;India;Medknow Publications;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
668;21127;Pharmaceutical Technology Europe;journal;17537967;0.129;Q4;16;153;250;696;11;178;0.03;4,55;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
669;130170;Phytotherapie;journal;17652847, 16248597;0.129;Q4;12;71;222;1680;24;151;0.1;23,66;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
670;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.128;Q4;9;22;61;573;17;55;0.27;26,05;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
671;19700201509;Pharma Research;journal;09758216;0.128;Q4;4;17;100;315;15;99;0.09;18,53;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
672;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.127;Q4;5;4;13;68;2;13;0.18;17,00;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
673;20543;Pharmacometrics;journal;03008533;0.127;Q4;6;0;30;0;7;30;0.21;0,00;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
674;21795;Farmaceuticky Obzor;journal;00148172;0.126;Q4;7;28;89;503;5;82;0.0;17,96;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q4)
675;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.126;Q4;7;6;39;200;12;39;0.26;33,33;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
676;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;0.126;Q4;4;43;101;531;10;100;0.11;12,35;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering (Q4); Drug Discovery (Q4)"
677;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.125;Q4;3;29;65;443;5;44;0.15;15,28;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
678;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.124;Q4;10;31;123;630;26;104;0.11;20,32;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q4); Critical Care and Intensive Care Medicine (Q4); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
679;25253;Blutalkohol;journal;00065250;0.124;Q4;13;32;85;409;6;83;0.07;12,78;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
680;22906;Journal of China Pharmaceutical University;journal;10005048;0.124;Q4;13;125;307;2573;47;307;0.17;20,58;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
681;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.123;Q4;3;0;1;0;0;1;0.0;0,00;Netherlands;Bentham Science Publishers B.V.;2012, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
682;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.123;Q4;1;1;1;13;0;1;0.0;13,00;India;IJLBPR Editorial Office;2012, 2014, 2016-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
683;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.123;Q4;1;0;1;0;0;1;0.0;0,00;India;International Journal of Pharma Medicine and Biological Sciences;2012, 2016-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
684;21100465007;International Research Journal of Pharmacy;journal;22308407;0.123;Q4;0;0;0;0;0;0;0.0;0,00;India;Moksha Publishing House;2012, 2014-ongoing;Pharmaceutical Science (Q4)
685;21716;Pharmazeutische Zeitung;journal;00317136;0.123;Q4;7;685;1853;855;9;1071;0.01;1,25;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
686;21100784233;Proceedings of the 2013 21st Euromicro International Conference on Parallel, Distributed, and Network-Based Processing, PDP 2013;conference and proceedings;00002013;0.123;-;0;0;1;0;0;1;0.0;0,00;United States;;2013;"Pharmaceutical Science; Statistics and Probability"
687;21100335701;Vaccines;journal;2076393X;0.123;Q4;24;42;1;3639;0;1;0.0;86,64;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
688;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.122;Q4;13;92;245;1285;27;245;0.1;13,97;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.121;Q4;11;142;410;3394;50;410;0.13;23,90;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
690;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.121;Q4;8;0;18;0;2;18;0.0;0,00;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
691;24097;Journal of the Indian Chemical Society;journal;00194522;0.121;Q4;31;285;767;8479;165;757;0.2;29,75;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
692;19700174997;ONdrugDelivery;trade journal;2049145X;0.121;Q4;5;54;140;190;9;109;0.1;3,52;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q4)
693;21142;Pharmaceutisch Weekblad;journal;00316911;0.12;Q4;9;385;1235;780;11;941;0.01;2,03;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
694;21100208082;VacciMonitor;journal;10250298, 1025028X;0.12;Q4;3;19;46;341;8;44;0.18;17,95;Cuba;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-ongoing;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
695;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.119;Q4;9;10;41;123;4;20;0.21;12,30;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
696;9100153105;Current Topics in Pharmacology;journal;09724559;0.118;Q4;4;11;40;681;6;40;0.11;61,91;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
697;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.118;Q4;9;79;287;0;39;275;0.23;0,00;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
698;4700152769;Pharmacopeial Forum;journal;03634655;0.118;Q4;16;9;55;194;5;44;0.11;21,56;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q3); Pharmacy (Q3); Pharmacology (Q4)"
699;19700174966;Pharmakeftiki;journal;11054999;0.118;Q4;2;10;29;627;5;24;0.21;62,70;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
700;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.117;Q4;18;44;71;637;7;69;0.02;14,48;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
701;13000154717;Current Topics in Toxicology;journal;09728228;0.117;Q4;6;11;22;426;7;22;0.11;38,73;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
702;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.117;Q4;11;28;183;811;26;181;0.1;28,96;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
703;19700201404;Open Drug Safety Journal;journal;18768180;0.116;Q4;3;0;11;0;5;11;0.0;0,00;Netherlands;Bentham Science Publishers B.V.;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
704;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.115;Q4;17;114;313;2018;30;281;0.12;17,70;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
705;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0.115;Q4;8;60;209;1565;29;207;0.07;26,08;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
706;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.114;Q4;5;18;43;671;7;41;0.14;37,28;Switzerland;Springer International Publishing AG;2007-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
707;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;0.114;Q4;3;29;102;504;11;100;0.05;17,38;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
708;19700175039;Open Toxicology Journal;journal;18743404;0.113;Q4;5;0;8;0;1;7;0.14;0,00;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology (Q4)
709;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.113;Q4;5;42;114;211;6;103;0.06;5,02;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
710;22358;U.S. Pharmacist;journal;01484818;0.113;Q4;7;160;467;2380;29;386;0.07;14,88;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
711;19700174925;European Pharmaceutical Review;trade journal;13608606;0.112;Q4;7;54;143;883;14;143;0.06;16,35;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
712;5200152843;Farmaceutico Hospitales;journal;02144697;0.112;Q4;3;0;21;0;1;13;0.0;0,00;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
713;19700188318;International Journal of Advances in Pharmaceutical Sciences;journal;09761055;0.112;Q4;10;0;6;0;2;6;0.0;0,00;United States;Advanced Research Journals;2010-2011 (cancelled);"Pharmaceutical Science (Q4); Physical and Theoretical Chemistry (Q4)"
714;19700174922;Chinese Journal of New Drugs;journal;10033734;0.111;Q4;9;555;1752;9599;146;1752;0.08;17,30;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
715;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.111;Q4;5;45;183;260;6;177;0.03;5,78;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
716;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.111;Q4;7;36;301;358;6;290;0.02;9,94;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
717;19700177006;Psychopharm Review;trade journal;19369255;0.111;Q4;4;2;36;103;7;36;0.17;51,50;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
718;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;0.11;Q4;4;12;39;263;5;32;0.16;21,92;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
719;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.108;Q4;7;28;28;966;5;28;0.18;34,50;United States;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
720;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0.108;Q4;13;6;3;700;0;3;0.0;116,67;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
721;19700174886;Arzneimitteltherapie;journal;07236913;0.107;Q4;6;177;453;1016;14;225;0.09;5,74;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
722;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.107;Q4;12;104;191;2580;11;191;0.08;24,81;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
723;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.107;Q4;14;4;65;220;8;65;0.0;55,00;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
724;19900192735;International Drug Discovery;journal;21504806, 21504792;0.107;Q4;4;0;32;0;6;32;1.0;0,00;United States;Russell Publishing LLC;2011-2012;Drug Discovery (Q4)
725;23107;Journal of Pharmacy Technology;journal;87551225;0.107;Q4;9;40;109;775;11;108;0.15;19,38;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
726;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.106;Q4;9;0;151;0;10;151;0.05;0,00;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
727;21100199794;Industrial Pharmacy;trade journal;17414911;0.106;Q4;4;16;59;110;6;59;0.05;6,88;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science (Q4)
728;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.106;Q4;3;1;12;33;1;10;0.1;33,00;United Kingdom;Taylor and Francis Inc.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
729;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.106;Q4;5;223;764;3583;34;764;0.04;16,07;China;Jilin University;2005-ongoing;Pharmacology (Q4)
730;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.106;Q4;5;0;4;0;1;4;0.25;0,00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
731;21243;Pharmacy times;trade journal;00030627;0.106;Q4;8;254;841;1434;13;336;0.05;5,65;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
732;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.106;Q4;2;0;4;0;1;4;0.0;0,00;Russian Federation;SRL Archive;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
733;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.105;Q4;13;372;406;7740;32;406;0.07;20,81;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
734;19200156912;EJHP Practice;journal;20303769, 17819989;0.105;Q4;5;0;93;0;7;70;0.0;0,00;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
735;21102;Pharmaceutical Journal;journal;00316873;0.105;Q4;25;335;1462;216;32;661;0.03;0,64;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
736;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;4;134;371;2001;14;371;0.03;14,93;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
737;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.104;Q4;2;0;109;0;2;64;0.0;0,00;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
738;19700175125;Internet Journal of Pharmacology;journal;15312976;0.104;Q4;7;0;6;0;0;6;0.0;0,00;United States;Internet Scientific Publications;2009-2011;Pharmacology (Q4)
739;19700175061;Open Pharmacology Journal;journal;18741436;0.104;Q4;6;0;10;0;1;9;0.13;0,00;United Arab Emirates;Bentham Science Publishers;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
740;19700175002;Pharmaceutical Reviews;journal;19185561;0.104;Q4;4;0;6;0;0;6;0.0;0,00;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
741;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.104;Q4;12;0;151;0;10;136;0.06;0,00;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
742;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.103;Q4;4;0;41;0;4;35;0.05;0,00;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
743;22887;Chinese Journal of Antibiotics;journal;10018689;0.103;Q4;10;204;514;3060;26;511;0.04;15,00;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
744;19700175108;Drug Delivery System;journal;09135006;0.103;Q4;7;60;83;778;3;83;0.02;12,97;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
745;21238;Drug Topics;journal;00126616;0.103;Q4;7;285;751;118;6;83;0.19;0,41;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
746;17716;Quality Assurance Journal;journal;10991786, 10878378;0.103;Q4;7;0;13;0;2;11;0.0;0,00;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
747;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.102;Q4;8;36;94;1819;2;69;0.02;50,53;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
748;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.102;Q4;6;34;72;0;2;72;0.0;0,00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
749;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.102;Q4;3;0;14;0;1;14;0.0;0,00;Poland;Medical University of Silesia;2010-2011;Pharmaceutical Science (Q4)
750;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.102;Q4;6;55;76;162;2;70;0.03;2,95;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
751;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;11;4;16;0;0;13;0.0;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
752;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.102;Q4;7;0;10;0;0;10;0.0;0,00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
753;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.102;Q4;4;58;97;1165;4;87;0.04;20,09;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
754;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.102;Q4;5;6;31;128;2;31;0.0;21,33;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
755;19700175034;Pharmaceutical Processing;trade journal;10499156;0.102;Q4;2;29;217;36;3;58;0.05;1,24;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
756;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.101;Q4;2;0;27;0;0;22;0.0;0,00;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
757;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.101;Q4;7;5;18;321;1;18;0.08;64,20;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
758;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.101;Q4;3;102;232;2657;6;227;0.01;26,05;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
759;19700173109;Contract Pharma;trade journal;15443469;0.101;Q4;3;126;459;173;4;413;0.01;1,37;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
760;21823;Farmatsija;journal;04280296;0.101;Q4;5;30;42;1091;1;42;0.04;36,37;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
761;21867;Geneesmiddelenbulletin;journal;03044629;0.101;Q4;6;48;190;837;4;100;0.02;17,44;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
762;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.101;Q4;7;0;27;0;1;27;0.0;0,00;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
763;22977;Journal de Pharmacie de Belgique;journal;00472166;0.101;Q4;12;27;92;0;3;83;0.04;0,00;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
764;22979;Journal of Applied Therapeutic Research;journal;10292659;0.101;Q4;7;0;17;0;0;17;0.0;0,00;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
765;21077;Pharmaca;journal;00316857;0.101;Q4;4;0;19;0;0;17;0.0;0,00;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
766;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;1;5;52;19;0;34;0.0;3,80;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
767;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;5;104;105;9908;3;55;0.5;95,27;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
768;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;2;19;52;134;0;52;0.0;7,05;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
769;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;2;31;89;445;0;76;0.0;14,35;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
770;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;60;181;230;2;169;0.01;3,83;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
771;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;0;74;0;0;68;0.0;0,00;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
772;21100202747;GMP Review;trade journal;14764547;0.1;Q4;2;6;56;20;2;55;0.05;3,33;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science (Q4)
773;13637;Manufacturing Chemist;journal;02624230;0.1;Q4;6;91;376;146;2;335;0.0;1,60;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
774;21100348334;Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future;conference and proceedings;00002013;0.1;-;1;0;74;0;1;72;0.01;0,00;United States;;2013;"Organic Chemistry; Pharmaceutical Science"
775;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135;0.1;Q4;1;0;88;0;1;88;0.0;0,00;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-2012;Pharmaceutical Science (Q4)
776;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;62;194;116;0;191;0.0;1,87;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
777;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;126;606;265;0;530;0.0;2,10;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
778;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;0;123;0;0;50;0.0;0,00;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
779;20572;PZ Prisma;journal;09455566;0.1;Q4;5;37;104;722;1;92;0.02;19,51;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
780;16800154712;Sp2;trade journal;1476184X;0.1;Q4;1;37;123;16;0;103;0.0;0,43;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
781;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;;-;6;38;0;3958;0;0;0.0;104,16;Germany;Springer Verlag;2014-ongoing;Pharmaceutical Science
782;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;;-;28;8;3;104;0;0;0.0;13,00;Netherlands;Elsevier BV;2014-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
783;21100841779;ADMET and DMPK;journal;18487718;;-;9;25;8;853;4;5;0.8;34,12;Croatia;International Association of Physical Chemists;2017-ongoing;"Chemistry (miscellaneous); Health (social science); Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
784;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;;-;9;6;0;346;0;0;0.0;57,67;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science; Pharmacology"
785;21100853016;Antibodies;journal;20734468;;-;5;2;0;131;0;0;0.0;65,50;Switzerland;MDPI AG;2014-ongoing;"Drug Discovery; Immunology; Immunology and Allergy"
786;21100853960;Anti-Tumor Pharmacy;journal;20951264;;-;1;11;0;284;0;0;0.0;25,82;China;Editorial Department of Anti-tumor Pharmacy;2014-ongoing;"Oncology; Pharmaceutical Science; Pharmacology (medical)"
787;21100818733;Archives of Pharmacy Practice;journal;2045080X;;-;2;1;0;35;0;0;0.0;35,00;India;Medknow Publications and Media Pvt. Ltd;2016-ongoing;Pharmaceutical Science
788;21100455212;Biomedical Reports;journal;20499434, 20499442;;-;15;4;0;129;0;0;0.0;32,25;Greece;Spandidos Publications;2014-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
789;21100853576;Bulletin of Faculty of Pharmacy, Cairo University;journal;11100931;;-;1;1;0;185;0;0;0.0;185,00;Egypt;Faculty of Pharmacy, Cairo University;2014;"Pharmaceutical Science; Pharmacy"
790;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22307583, 22497226;;-;0;2;0;35;0;0;0.0;17,50;India;International Journal of Advances in Pharmaceutical Research;2014-2015;"Drug Discovery; Pharmaceutical Science"
791;21100853873;International Journal of Current Pharmaceutical Research;journal;09757066;;-;3;1;0;21;0;0;0.0;21,00;India;Innovare Academic Sciences Pvt Ltd.;2014-ongoing;Pharmaceutical Science
792;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;;-;3;2;0;107;0;0;0.0;53,50;United States;Hindawi Publishing Corporation;2014-ongoing;"Biochemistry; Drug Discovery; Molecular Medicine"
793;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22496084, 22501029;;-;1;4;0;117;0;0;0.0;29,25;India;International Journal of Pharmaceutical and Phytopharmacological Research;2014-2015;"Drug Discovery; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100854242;International Nano Letters;journal;22285326, 20089295;;-;1;1;0;18;0;0;0.0;18,00;United States;Springer Science + Business Media;2014;"Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
795;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;;-;11;20;0;560;0;0;0.0;28,00;Germany;Elsevier GmbH;2014-ongoing;"Drug Discovery; Plant Science"
796;21100853985;Journal of Xenobiotics;journal;20394705;;-;2;2;0;53;0;0;0.0;26,50;Italy;PagePress Publications;2014-ongoing;"Pharmacology; Pollution; Toxicology"
797;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;273;822;6317;325;822;0.42;23,14;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
798;21100854337;MicroRNA Diagnostics and Therapeutics;journal;20846843;;-;2;4;0;398;0;0;0.0;99,50;Poland;De Gruyter Open Ltd.;2014;"Drug Discovery; Genetics (clinical); Molecular Medicine"
799;21100426011;Nano LIFE;journal;17939852, 17939844;;-;1;1;0;32;0;0;0.0;32,00;Singapore;World Scientific Publishing Co. Pte Ltd;2014-2015;"Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
800;19700175105;Open Drug Delivery Journal;journal;18741266;;-;5;1;0;13;0;0;0.0;13,00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science
801;21100205919;Open Drug Discovery Journal;journal;18773818;;-;8;1;0;33;0;0;0.0;33,00;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery
802;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;;-;2;2;0;109;0;0;0.0;54,50;New Zealand;Dove Medical Press Ltd.;2017-ongoing, 2014-ongoing;"Drug Discovery; Pharmaceutical Science"
803;21100854648;Pharmaceutical Crops;journal;22102906;;-;1;1;0;158;0;0;0.0;158,00;Netherlands;Bentham Science Publishers B.V.;2014, 2016-ongoing;"Pharmaceutical Science; Plant Science"
804;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;;-;3;5;0;357;0;0;0.0;71,40;Netherlands;Bentham Science Publishers B.V.;2014-ongoing;"Biomedical Engineering; Pharmaceutical Science"
805;21100854216;Pharmanest;journal;09763090, 22310541;;-;0;2;0;30;0;0;0.0;15,00;India;Pharmaceutical Education and Research Society;2014-2015;"Biochemistry; Biomedical Engineering; Biotechnology; Pharmaceutical Science"
806;21100446017;Proceedings of the 16th International Association for Mathematical Geosciences - Geostatistical and Geospatial Approaches for the Characterization of Natural Resources in the Environment: Challenges, Processes and Strategies, IAMG 2014;conference and proceedings;00002014;;-;2;148;0;1209;0;0;0.0;8,17;India;;2014;"Organic Chemistry; Pharmaceutical Science"
807;19700174987;Research Journal of Toxins;journal;18193560;;-;2;1;0;30;0;0;0.0;30,00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science; Food Science; Toxicology"
808;21100201517;RSC Drug Discovery Series;book series;20413203;;-;7;18;0;1268;0;0;0.0;70,44;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery
809;21100291830;Selenium in the Environment and Human Health - Proceedings of the 3rd International Conference on Selenium in the Environment and Human Health;conference and proceedings;00002014;;-;4;92;0;690;0;0;0.0;7,50;Netherlands;;2014;"Health, Toxicology and Mutagenesis; Toxicology"
810;21100777378;Therapeutic Advances in Vaccines;journal;20510136;;-;5;6;0;790;0;0;0.0;131,67;United States;SAGE Publications Inc.;2014-2015;"Drug Discovery; Immunology; Immunology and Allergy; Oncology; Pharmacology (medical)"
811;21100367469;Toxicology Reports;journal;22147500;;-;21;130;0;5536;0;0;0.0;42,58;Ireland;Elsevier Scientific Publishers Ireland;2014-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
812;21100830708;Toxics;journal;23056304;;-;12;28;7;1795;7;6;1.17;64,11;Switzerland;MDPI AG;2017-ongoing;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
